Healthcare Sector

Members of Parliament invested in the Healthcare Sector

140 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£134.96	212.12%	£218,482.89
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£134.96	192.56%	£204,795.15
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£10,244.00	-14.80%	£59,637.39
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£10,244.00	148.88%	£174,217.69
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£10,244.00	164.26%	£184,981.30
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£10,244.00	38.02%	£96,615.47
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£10,244.00	-12.99%	£60,903.69
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£10,244.00	284.17%	£268,921.81
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£10,244.00	-15.73%	£58,989.80
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£10,244.00	89.11%	£132,375.85
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£10,244.00	-14.09%	£60,137.54
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£10,244.00	0.14%	£70,095.80
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£10,244.00	27.97%	£89,579.01
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£10,244.00	248.67%	£244,070.80
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.28	-91.54%	£5,921.45
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£33.43	-10.59%	£62,586.26
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£33.43	-37.43%	£43,797.49
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£33.43	-21.86%	£54,700.80
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£33.43	-15.11%	£59,423.56
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£33.43	-20.99%	£55,308.44
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£33.43	-15.35%	£59,258.04
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£33.43	-25.30%	£52,292.74
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£33.43	-24.06%	£53,159.93
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£143.58	-13.00%	£60,901.66
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£143.58	17.07%	£81,952.06
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£143.58	97.52%	£138,266.61
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£143.58	135.65%	£164,953.23
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£226.16	148.69%	£174,084.56
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£226.16	213.44%	£219,407.70
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£226.16	-9.13%	£63,609.01
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£226.16	214.64%	£220,246.59
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£231.10	83.27%	£128,287.08
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£489.25	93.21%	£135,248.01
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£489.25	-0.17%	£69,884.30
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£489.25	-9.03%	£63,677.18
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£489.25	121.22%	£154,853.95
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,206.02	79.34%	£125,535.55
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£516.69	23.57%	£86,498.06
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£516.69	-9.50%	£63,348.69
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£516.69	139.24%	£167,469.09
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£516.69	12.51%	£78,756.86
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£516.69	24.15%	£86,907.51
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£138.00	-77.47%	£15,768.85
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£138.00	-56.88%	£30,187.50
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£103.44	184.57%	£199,196.71
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£103.44	-18.85%	£56,808.41
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£103.44	1.72%	£71,204.64
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£103.44	82.42%	£127,692.44
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£103.44	-15.73%	£58,988.19
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£103.44	-23.18%	£53,770.98
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£163.52	-2.72%	£68,092.80
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£96.77	9.49%	£76,645.17
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£96.77	46.51%	£102,559.66
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£96.77	79.07%	£125,346.91
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£96.77	1.01%	£70,708.76
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£225.00	-1.10%	£69,230.77
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£246.70	-2.04%	£68,568.59
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£246.70	-20.33%	£55,769.42
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£246.70	-3.56%	£67,509.77
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£112.42	344.94%	£311,458.74
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£112.42	3.31%	£72,315.75
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£112.42	241.70%	£239,191.47
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£16.76	-83.44%	£11,592.89
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£25.77	31.85%	£92,296.63
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£25.77	-11.21%	£62,154.65
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£24.79	9.67%	£76,766.06
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£24.79	18.16%	£82,710.56
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£360.63	314.09%	£289,862.23
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£357.14	414.46%	£360,123.91
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£357.14	29.87%	£90,908.37
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£35.70	7.01%	£74,910.07
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£35.70	-25.31%	£52,280.34
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£35.70	-35.03%	£45,477.71
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£1.36	-89.38%	£7,431.69
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£43.78	-44.89%	£38,577.54
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£43.78	-16.86%	£58,195.97
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£18.87	-80.19%	£13,866.26
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£213.58	-21.98%	£54,614.06
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£171.52	6.66%	£74,662.03
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£88.66	125.48%	£157,838.26
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£523.91	88.56%	£131,990.99
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£523.91	84.36%	£129,050.95
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£523.91	49.35%	£104,546.02
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£5.00	-89.16%	£7,590.54
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£1.19	-65.80%	£23,936.78
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£1.18	-94.43%	£3,896.23
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£297.52	859.12%	£671,386.18
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£24.00	-4.04%	£67,172.59
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£1,516.00	-43.39%	£39,626.59
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£6.19	-25.51%	£52,142.00
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£409.03	1,265.25%	£955,677.60
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£757.54	3.58%	£72,508.71
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,935.00	-4.49%	£66,855.87
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£4.14	-90.44%	£6,694.39
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.49	-86.19%	£9,664.82
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£730.00	31.06%	£91,741.47
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£9.96	611.43%	£498,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£4.65	24.33%	£87,032.09
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£4.40	-38.29%	£43,197.76
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£1.74	-9.37%	£63,437.50
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.17	-84.13%	£11,105.77
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£30.95	105.65%	£143,953.49
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.60	-59.18%	£28,571.43
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£1.80	-85.00%	£10,500.00
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£4.26	-59.89%	£28,079.10
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£7.75	-31.11%	£48,222.22
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£24.28	-19.28%	£56,502.66
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£39.56	-64.67%	£24,729.42
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£9.35	-78.68%	£14,925.88
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£380.60	13.24%	£79,268.07
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.39	-84.15%	£11,097.56
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£1.28	-89.88%	£7,083.00
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£231.90	11.76%	£78,231.32
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£2.63	-89.90%	£7,067.31
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£48.00	-57.14%	£30,000.00
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£75.21	330.51%	£301,356.62
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£9.23	172.27%	£190,589.96
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£2.12	-92.93%	£4,946.67
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.90	-1.27%	£69,113.92

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.